[原著］Clinical Study of Rectal Administration of FT 207 in Patients with Advanced Gastromtestinal Cancer

概要

論文の詳細を見る
We have administered by rectumFT 207 to inoperable cases, recurrent cases or those cases who had undergone palliative operation. Twenty three cases were treated with this method: nine cases of gastric cancer, four cases of colon cancer, four cases of rectal cancer, three cases of hepatoma, a case of biliary tract cancer, a case of liver metastasis from esophageal cancer, and a case of cancer of the anus. Daily dosage was 750 mg or 1500 mg, and the total dose ranged from 15.5g to 574.5g. Other drugs (Neocarcinostatin or Mitomycin C and Picibanil or Kresin) were also administered. According to Karnofsky's criteria, the results were as follows:six cases of O-O, a case of O-A, none of O-B. a case of O-C, seven of 1-A, four cases of 1-B, two cases of 1-C and two of unknown classification. A total of thirteen of the twenty one cases showed more than 1-A.
琉球大学医学部の論文
1983-00-00